Resources from the same session
57MO - First-line (1L) ribociclib (RIB) + endocrine therapy (ET) vs combination chemotherapy (combo CT) in HR+/HER2− advanced breast cancer (ABC): A post hoc analysis of Asian and non-Asian patients (pts) from the phase II RIGHT choice trial
Presenter: Govind Babu Kanakasetty
Session: Mini oral session: Breast cancer
Resources:
Abstract
Slides
Webcast
Invited Discussant LBA3, LBA6 and 57MO
Presenter: Mastura Md Yusof
Session: Mini oral session: Breast cancer
Resources:
Slides
Q&A and discussion
Presenter: All Speakers
Session: Mini oral session: Breast cancer
Resources:
Webcast